Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis

Annals of the Rheumatic Diseases

Volumn 73, Issue 6, 2014, Pages 1083-1090

  Malattia, Clara ^a,b   Damasio, Maria Beatrice ^a   Madeo, Annalisa ^a   Pistorio, Angela ^a   Providenti, Anna ^a   Pederzoli, Silvia ^a   Viola, Stefania ^a   Buoncompagni, Antonella ^a   Mattiuz, Chiara ^a   Beltramo, Agnese ^a   Consolaro, Alessandro ^a   Ravelli, Angelo ^a,b   Ruperto, Nicolino ^a   Picco, Paolo ^a   Magnano, Gian Michele ^a   Martini, Alberto ^a,b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD MYOSITIS ASSESSMENT SCALE; CLINICAL ARTICLE; CONSTRUCT VALIDITY; CONTROLLED STUDY; DISCRIMINANT VALIDITY; DISEASE ACTIVITY; FASCIA; FEMALE; FOLLOW UP; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; JUVENILE DERMATOMYOSITIS; MALE; MUSCLE STRENGTH; MYOFASCIA; NUCLEAR MAGNETIC RESONANCE SCANNER; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; REMISSION; SCHOOL CHILD; SCORING SYSTEM; SKELETAL MUSCLE; SUBCUTANEOUS TISSUE; WHOLE BODY MRI;

DERMATOMYOSITIS; DISEASE ACTIVITY; MAGNETIC RESONANCE IMAGING;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; DERMATOMYOSITIS; FASCIA; FEASIBILITY STUDIES; FEMALE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; PHYSICAL EXAMINATION; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SUBCUTANEOUS TISSUE; WHOLE BODY IMAGING;

EID: 84899983885     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202915     Document Type: Article

References (45)

1. McCann LJ, Juggins AD, Maillard SM, et al.; Juvenile Dermatomyositis Research Group. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)-clinical characteristics of children recruited within the first 5 yr. Rheumatology (Oxford). 2006;45: 1255-60. (Pubitemid 44542066)
2. Mendez EP, Lipton R, Ramsey-Goldman R, et al. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003;49: 300-5. (Pubitemid 36682395)
3. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325: 1487-98.
4. Huber AM, Lang B, LeBlanc CM, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000;43: 541-9. (Pubitemid 30394944)
5. Ravelli A, Trail L, Ferrari C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken) 2010;62: 63-72.
6. Ravelli A, Ruperto N, Trail L, et al. Clinical assessment in juvenile dermatomyositis. Autoimmunity 2006;39: 197-203. (Pubitemid 43879032)
7. Rider LG, Werth VP, Huber AM, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S118-57.
8. Hernandez RJ, Sullivan DB, Chenevert TL, et al. MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. AJR Am J Roentgenol 1993;161: 359-66. (Pubitemid 23224804)
9. Park JH, Vital TL, Ryder NM, et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994;37: 736-46. (Pubitemid 24145079)
10. Keim DR, Hernandez RJ, Sullivan DB. Serial magnetic resonance imaging in juvenile dermatomyositis. Arthritis Rheum 1991;34: 1580-4.
11. Maillard SM, Jones R, Owens C, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) 2004;43: 603-8. (Pubitemid 38628191)
12. Hernandez RJ, Keim DR, Sullivan DB, et al. Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis. J Pediatr 1990;117: 546-50. (Pubitemid 20332092)
13. Hernandez RJ, Keim DR, Chenevert TL, et al. Fat-suppressed MR imaging of myositis. Radiology 1992;182: 217-19.
14. Tomasová Studynková J, Charvát F, Jarosová K, et al. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology (Oxford) 2007;46: 1174-9. (Pubitemid 47050625)
15. Pitt AM, Fleckenstein JL, Greenlee RG Jr, et al. MRI-guided biopsy in inflammatory myopathy: initial results. Magn Reson Imaging 1993;11: 1093-9.
16. O'Connell MJ, Powell T, Brennan D, et al. Wholebody MR imaging in the diagnosis of polymyositis. AJR Am J Roentgenol 2002;179: 967-71.
17. Cantwell C, Ryan M, O'Connell M, et al. A comparison of inflammatory myopathies at whole-body turbo STIR MRI. Clin Radiol 2005;60: 261-7. (Pubitemid 40123500)
18. Tzaribachev N, Well C, Schedel J, et al. Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature. Rheumatol Int 2009;29: 1511-14.
19. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292: 344-7.
20. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292: 403-7.
21. Hicks J, Wesley R, Koziol D, et al. Validation of manual muscle testing in the assessment of juvenile dermatomyositis. Arthritis Rheum 2000;43(Suppl):S194.
22. Hicks J, Wesley R, Koziol D, et al. Preliminary validation of abbreviated manual muscle testing in the assessment of juvenile dermatomyositis. Arthritis Rheum 2000;43(Suppl):S195.
23. Lovell DJ, Lindsley CB, Rennebohm RM, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999;42: 2213-19. (Pubitemid 30263608)
24. Huber AM, Feldman BM, Rennebohm RM, et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004;50: 1595-603. (Pubitemid 38608082)
25. Feldman BM, Ayling-Campos A, Luy L, et al. Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. J Rheumatol 1995;22: 326-31.
26. Huber AM, Hicks JE, Lachenbruch PA, et al. Validation of the childhood health assessment questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. J Rheumatol 2001;28: 1106-11. (Pubitemid 32422597)
27. Filocamo G, Schiappapietra B, Bertamino M, et al. A new short and simple health-related quality of life measurement for paediatric rheumatic diseases: initial validation in juvenile idiopathic arthritis. Rheumatology (Oxford) 2010;49: 1272-80.
28. Bode RK, Klein-Gitelman MS, Miller ML, et al. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003;49: 7-15. (Pubitemid 36286124)
29. Ruperto N, Ravelli A, Murray KJ, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42: 1452-9. (Pubitemid 37508918)
30. Miller FW, Rider LG, Chung YL, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001;40: 1262-73.
31. Ruperto N, Pistorio A, Ravelli A, et al. The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis Care Res (Hoboken). 2010;62: 1533-41.
32. Lazarevic D, Pistorio A, Palmisani E, et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 2013;72:686-93.
33. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Meth Med Res 1999;8: 135-60. (Pubitemid 29425900)
34. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20: 37-46.
35. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33: 159-74. (Pubitemid 8054849)
36. Liang MH, Larson MG, Cullen KE, et al. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28: 542-7. (Pubitemid 15109906)
37. Dorph C, Englund P, Nennesmo I, et al. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis. Ann Rheum Dis 2006;65: 1565-71. (Pubitemid 44799666)
38. Garcia J. MRI in inflammatory myopathies. Skeletal Radiol 2000;29: 425-38. (Pubitemid 30662259)
39. Ladd PE, Emery KH, Salisbury SR, et al. Juvenile dermatomyositis: correlation of MRI at presentation with clinical outcome. AJR Am J Roentgenol 2011;197: W153-8.
40. Kimball AB, Summers RM, Turner M, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000;43: 1866-73.
41. Ley S, Ley-Zaporozhan J, Schenk JP. Whole-body MRI in the pediatric patient. Eur J Radiol 2009;70: 442-51.
42. Adams EM, Chow CK, Premkumar A, et al. The idiopathic inflammatory myopathies: spectrum of MR imaging findings. Radiographics 1995;15: 563-74.
43. Fraser DD, Frank JA, Dalakas M, et al. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991;18: 1693-700.
44. Krug B, Kugel H, Schulze HJ, et al. High-resolution MR imaging of the cutis and subcutis: histological correlation. Acta Radiol 1998;39: 547-53. (Pubitemid 128456057)
45. Yoshida K, Kurosaka D, Joh K, et al. Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging. Arthritis Rheum 2010;62: 3751-9.